
0913693 B.c. (OTC: REPCF)
$0.00
(5.3%)
$0.00
Price as of February 19, 2025, 11:43 a.m. ET
0913693 B.c. Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
0913693 B.c. Company Info
RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in developing cell therapies for aesthetic and orthopedic conditions. Its products include RCH-01, RCS-01, RCT-01, and DermaPrecise. The company was founded by Kevin McElwee and Rolf Hoffmann on April 24, 1967 and is headquartered in Vancouver, Canada.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.